Taken together, our findings demonstrate that tRF-24 modulates CELF1-mediated alternative splicing of BIN1 and BECN1, promoting DNA damage repair, cisplatin resistance and glycolytic metabolism in ESCC. This evidence concerns the gene BECN1 and esophageal squamous cell carcinoma.